NYKODE THERAPEUTICS ASA financial statements, including revenue, expenses, profit, and loss

The total revenue of NYKD for the last quarter is 5.85 M NOK, and it's 32.75% lower compared to the previous quarter. The net income of Q2 24 is -79.47 M NOK.